Thiotepa

This classification denotes an ethylenimine compound with the molecular formula C6H12N3PS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 905Z5W3GKH, chemically known as 1,1,1-phosphinothioylidynetrisaziridine but more generally known as thiotepa, which bears US NIH Compound Identifier 5453. European Medicines Agency schedules Thiotepa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10985MIG. The term THIOTEPA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules thiotepa in its Anatomical Therapeutic Chemical (ATC) Classification. THIOTEPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule thiotepa under HS 29339990 and SITC 51577. As of Q4 2014, THIOTEPA remains US FDA's Preferred Term for this commodity. Thiotepa bears US NLM identifiers UMLS ID C0039871 and NCI Concept Code C875. SMILES: S=P(N1CC1)(N1CC1)N1CC1.